Leslie Walton, Research Labs

Date:
10 May 2001
Reference:
WF/M/AV/O/02/17
Part of:
Wellcome Foundation Ltd
  • Archives and manuscripts

About this work

Description

**Please note there is no release form associated with this interview.**

Les Watson joined BW in the UK in 1968. He was based at the Beckenham labs and worked under Dr Stan Bushby and [Dr?] Margaret Barnett. In 1970 he moved with them to BW in the USA as part of the team responsible for getting FDA approval for Septra/Septrin. After the mergers, he continued working for Glaxo Wellcome and then GSK.

Topics discussed:

* induction and training at Beckenham

* Septra/Septrin, the relocation to USA to gain approval for the drug, the joint venture with Johnson and Johnson

* comparison of USA nd UK research, including working atmosphere and commercial vs pure research focus

* impressions of Research Triangle Park and the working atmosphere

* Gertrude Elion

* McKinsey Report

* development and focus of research

* monochrome antibody research

* flotation

* AZT and Aids, including protests re pricing

* merger with Glaxo: staff attitudes towards it, difference in BW and Glaxo management style

* working relationship between UK and USA.

Publication/Creation

10 May 2001

Physical description

audio tape and transcript Tape 19

Copyright note

Copyright remains the property of interviewee.

Terms of use

This item is closed and cannot be accessed. Please see our Access Policy for more details. Closed until 1 January 2053.

Where to find it

  • LocationStatusAccess
    Closed stores
    WF/M/AV/O/02/17:Box 2
    ClosedCan't be requested

Permanent link